They focused on kidney transplant Covid-19 patient
Post# of 148174
18 doctors from Montifiore Medical Center submitted this information to NEJM; they must have much faith in our Leronlimab. I suspect it's because of the detailed medical submission the Journal decided to publish an upcoming article.
Enver Akalin, M.D.
Yorg Azzi, M.D.
Rachel Bartash, M.D.
Harish Seethamraju, M.D.
Michael Parides, Ph.D.
Vagish Hemmige, M.D.
Michael Ross, M.D.
Stefanie Forest, M.D., Ph.D.
Yitz D. Goldstein, M.D.
Maria Ajaimy, M.D.
Luz Liriano-Ward, M.D.
Cindy Pynadath, M.D.
Pablo Loarte-Campos, M.D.
Purna B. Nandigam, M.D.
Jay Graham, M.D.
Marie Le, M.D.
Juan Rocca, M.D.
Milan Kinkhabwala, M.D.
Montefiore Medical Center, Bronx, NY
eakalin@montefiore.org
Does anyone know if this is the type of information that makes up the "human data" we are to submit to the FDA?